Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis

Published:2018-08-22 Issue:6 Volume:18 Page:483-492
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Yuan Jun^ORCID,Xu Guang Ma

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s40256-018-0295-y/fulltext.html

Reference23 articles.

1. Bundhun PK, Bhurtu A, Soogund MZ, Long MY. Comparing the clinical outcomes between drug eluting stents and bare metal stents in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 10 randomized controlled trials. PLoS One. 2016;11(4):e0154064.

2. Partida RA, Yeh RW. Contemporary drug-eluting stent platforms: design, safety, and clinical efficacy. Interv Cardiol Clin. 2016;5(3):331–47.

3. Bundhun PK, Soogund MZ, Pursun M, Chen MH. Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with type 2 diabetes mellitus complicated by coronary artery disease: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(27):e4130.

4. Kadohira T, Kobayashi Y, Asano T, Uehara M, Funabashi N, Nakayama T, Kuroda N, Komuro I. Fatal very late stent thrombosis in a young diabetic patient with severely diffuse coronary atherosclerosis. Int Heart J. 2008;49(4):507–13.

5. Arthur JF, Jandeleit-Dahm K, Andrews RK. Platelet hyperreactivity in diabetes: focus on GPVI signaling-are useful drugs already available? Diabetes. 2017;66(1):7–13.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies;Life Sciences;2024-09

2. Diabetic conditions promote drug coating degradation but prevent endothelial coverage after stenting;Acta Biomaterialia;2024-03

3. Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions;Journal of Clinical Medicine;2023-11-28

4. Peri-Coronary Adipose Tissue Is a Predictor of Stent Failure in Patients Undergoing Percutaneous Coronary Intervention;Cardiovascular Revascularization Medicine;2023-08

5. High rate of uncovered struts in latest generation drug-eluting stents with durable, biodegradable polymer or lack of it 1 month after implantation;REC: interventional cardiology (English Edition);2023-02-07